Pharma M&A: Agile Shouldn’t Mean Ad Hoc

By Ankur Agrawal, Ruth De Backer, Spring Liu – McKinsey & Company Contributors: Alvaro Aguero, Matthew Van Wingerden Under pressure to be active acquirers, some pharmaceutical and...

Loading.. Please wait